Our ESG Strategy

Lilly's greatest contribution to society is the discovery and development of innovative medicines that make life better for people around the world. Our impact extends to how we operate our business, care for the environment and strengthen communities. Our Environmental, Social and Governance (ESG) strategy and efforts are guided by our impact framework. This framework leads with our purpose to create medicines that make life better, and includes five pillars that guide how we operate and contribute to the world.

CREATE MEDICINES THAT MAKE LIFE BETTER
Increase Access to Medicines
Improves Lives and Communities
Empower a Diverse Workforce
Minimize Our Environmental Impact
Operate Ethically and Responsibly
hand holding floating heart icon

Create Medicines That Make Life Better

Approximately 45 million people globally rely on Lilly’s medicines. For nearly 150 years, we’ve developed and delivered trusted medicines that help people get better, feel better and live better.

generic pill bottle icon

Increase Access to Medicines

Around the world, too many people, especially the most vulnerable, lack access to the medicines and care they need. Reaching across industry boundaries, we collaborate with leading health organizations, providers, regulators and governments to find new solutions that help address access challenges and strengthen health care systems. We’ve established an aggressive goal – Lilly 30x30 – to improve annual access to quality health care for 30 million people living in communities with limited resources by 2030.

people in front of house icon

Improve Lives and Communities

Beyond our medicines, we invest our time, expertise and resources to drive social impact, with a focus on improving health. We also address targeted social issues that affect our business and employees, with an emphasis on racial justice and education. We encourage our employees to volunteer and give in ways that advance our purpose and theirs.

team lifting flag icon

Empower a Diverse Workforce

Diversity and inclusion are foundational to Lilly’s business of innovation. We believe when we harness a variety of perspectives, it helps us discover and deliver life-changing medicines. Lilly is committed to welcoming, respecting and valuing that which makes each of us unique. When team members come to work each day, they bring different experiences, perspectives and traditions. As a major employer, we also take action on racial justice issues that affect our employees, business and communities.

hands holding up earth icon

Minimize Our Environmental Impact

Making medicines requires the use of valuable resources including energy, water and raw materials. We’re committed to improving our environmental impact across the life cycles of our products and our supply chain – with a focus on addressing climate change, waste and water security.

two hands holding in shape of heart icon

Operate Ethically and Responsibly

It’s who we are. It’s the foundation of how we conduct business and create positive change for people and communities, while minimizing our environmental impact. Our core values of integrity, excellence and respect for people have guided us since the beginning, and they remain at the heart of all we do today.

Loading...
Loading...

Lilly’s ESG Priorities

Environmental Social Governance
Environmental: Social: Governance:
Environmental: Social: Governance:
Environmental: Social: Governance:
Environmental: Social: Governance:
Environmental:
Social: Governance:
Environmental:
Social: Governance:

ESG Governance

Our board and management are actively engaged in the assessment, management and oversight of matters pertinent to our business.

Learn more

Our Commitment to the Sustainable Development Goals

Loading...
Loading...
Loading...
Loading...

This website contains forward-looking statements that are based on management’s current assumptions and expectations, including statements regarding our sustainability targets, goals, commitments and programs and other business plans, initiatives and objectives. The words “estimate”, “project”, “intend”, “expect”, “believe”, “target”, “anticipate” and similar expressions are intended to identify forward-looking statements. All such statements are intended to enjoy the protection of the safe harbor for forward-looking statements provided by the Private Securities Litigation Reform Act of 1995, as amended. Actual results may differ materially due to various factors. The company’s sustainability targets, goals, and commitments outlined in this website or elsewhere, as well as its operations, results, business, goals, and strategy may be affected by factors including, but not limited to, the impact of the evolving COVID-19 pandemic and the global response thereto; the significant costs and uncertainties in the pharmaceutical research and development process, including with respect to the timing and process of obtaining regulatory approvals; competitive developments affecting current products and the company’s pipeline; regulatory actions regarding currently marketed products; litigation, investigations, or other similar proceedings involving past, current, or future products or commercial activities as the company is largely self-insured; the impact of business development transactions and related integration costs; the impact of global macroeconomic conditions and trade disruptions or disputes; and changes or developments in laws and regulations, including health care reform.

For additional information about the factors that affect the company’s business, please see the company’s latest Forms 10-K, 10-Q, and any 8-Ks filed with the Securities and Exchange Commission. The company expressly disclaims any obligation to update forward-looking statements except as required by applicable law.